Skip to main content

8110 Gatehouse Road, Falls Church, VA 22042

Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

Translate

General Information

Age Group

Adults

Status

Active, not recruiting

Protocol Number

NCT02928497

Background Information

The ASAP-TOO study is a prospective, randomized, multi-center, global investigation to establish the safety and effectiveness of the Watchman Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anti-coagulation therapy to reduce the risk of stroke. Subjects are randomized in a ratio of 2 device to 1 control to receive the Watchman LAA closure device or the control treatment of single antiplatelet medication or no medication at the discretion of the study physician.

Offered At

Inova Fairfax Hospital
3300 Gallows Rd.
Falls Church, VA 22042

Principal Investigator

Matthew Sherwood, MD